Across TCGA pan-cancer cohorts, CDKN2AIPNLP3 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of CDKN2AIPNLP3’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where CDKN2AIPNLP3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CDKN2AIPNLP3 is over-expressed in tumor.

BRCA are the cancer types where CDKN2AIPNLP3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDKN2AIPNLP3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.017	.034	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CDKN2AIPNLP3 RNA expression & survival · all CDKN2AIPNLP3 data types